In the world of pharmaceutical research, the ability to collect, analyze and disseminate electronically captured patient-centric and disease-selective data is critical. From electronic clinical outcome assessments (eCOA) to wearable devices and advanced sensors, the demand for cutting-edge, efficient and objective measurement solutions is growing faster than ever. How can digital health companies stay ahead of the curve to meet the evolving needs of their pharmaceutical partners?
This webinar delves into the transformative role of innovation labs. The expert speakers will explore how a dedicated innovation team fuels creativity, accelerates development and drives groundbreaking advancements in eCOA, wearable technologies and sensor solutions.
Attendees will get to learn how an agile environment fosters rapid prototyping, cross-disciplinary collaboration and data-driven decision-making, enabling pharmaceutical partners to streamline clinical trials, improve patient outcomes and meet regulatory demands faster than traditional approaches.
They will gain insights into the methodologies that the innovation lab uses to stay ahead from evaluating emerging wearable sensor solutions to leveraging artificial intelligence (AI) and machine learning. Whether a pharmaceutical professional or a digital health innovator, this webinar will provide actionable strategies for leveraging innovation labs to create more efficient, data-driven, patient-centric solutions.
Register for this webinar to discover how innovation labs fuel cutting-edge advancements in wearable technologies, AI-driven insights and rapid prototyping to enhance clinical trial efficiency.
Speakers
Dr. Josh Cosman, PhD, Scientific Director, Precision Medicine, Abbvie Inc.
Dr. Josh Cosman is an interdisciplinary neuroscientist with 20 years’ experience developing behavioral and electrophysiological markers of cognition and motor function in healthy aging and neurological disorders. For the past decade his work has focused on supporting therapeutic development, leading development of translational biomarkers and novel functional markers using scalable research-grade tools and consumer devices. He is actively involved in several precompetitive initiatives in both the digital health and translational neuroscience fields, including serving as industry co-director or the Critical Path for Parkinson’s ‘Digital Drug Development Tools’ consortium.
Message Presenter
Andrew Kraus, Chief Technology Officer, Clinical ink
Andrew Kraus brings nearly 30 years of business strategy, operational excellence and technology innovation to his role as Chief Technology Officer at Clinical ink. With a strong focus on integrating business needs and requirements into IT planning and operations, Andrew is instrumental in driving our technology advancements. Prior to Clinical ink, Kraus served as Chief Operating Officer for World Care Clinical, a CRO providing centralized imaging and other services supporting clinical trials. He currently sits on the Board of Directors for Algorics, a specialized clinical data services company.
Read more...
Read Less...
Dr. David Anderson, PhD, Director, Science & Innovation, Clinical ink
Dr. David Anderson is the Director of Science and Innovation at Clinical ink where he leads the innovation lab and collaborates with an interdisciplinary team of engineers and scientists.
His work involves integrating data from multiple sensors and assessments, implementing high-dimensional feature engineering pipelines, evaluating scalable machine learning algorithms and developing dynamic real-time dashboard visualizations to support clinical trial decision-making.
Dr. Anderson is a neuroscientist by training and education with over sixteen years of experience developing hardware and software solutions to evaluate human behavior and physiology in both laboratory and real-world environments.
Message Presenter
Megan Petrylak, Chief Operating Officer, Clinical ink
With over 17 years of clinical trial experience, including 14 years in operational leadership roles, Megan Petrylak plays a key role at Clinical ink. She oversees all customer, site and patient-facing operations, enhancing Clinical ink’s capabilities in data management and quality assurance. Her commitment to fostering a quality-first culture has led to remarkable improvements in customer satisfaction, reduced study build and execution times and outstanding quality outcomes.
Read more...
Beyond her extensive expertise in eCOA, project management and data management, Megan is a dedicated team builder who believes that exceptional customer satisfaction begins with nurturing and supporting employees.
Read Less...
Dr. Nicholas Alp, MD, PhD, FACC, Chief Medical Officer, Clinical ink
Dr. Nicholas Alp has more than 30 years of clinical research experience as an academic cardiologist, clinical trialist and commercial drug development expert. Before joining Clinical ink, he was Senior Vice President and Head of Cardiometabolic Research at Medpace, a global clinical research organization. Previously, Dr. Nicholas was Vice President and Global Head of Cardiovascular Drug Development at ICON.
Read more...
Dr. Nicholas trained in medicine at London University and Oxford University completed a PhD in Immunology at Cambridge University, with a further post-doctoral DM degree in Cardiology at Oxford University. He has also contributed to more than 70 peer-reviewed publications and books.
Read Less...
Dr. Steve Polyak, PhD, Senior Vice President, Global Head of Product Innovation, Clinical ink
Dr. Steve Polyak is Senior Vice President, Global Head of Product Innovation at Clinical ink where he leads innovation, architecture and product design for new clinical trial capabilities. His organizational scope includes an innovation lab staffed with engineers, designers and scientists working on connected device integrations, wearables, sensors and digital biomarkers for therapeutic areas, including diabetes, weight management and movement disorders such as Parkinson’s disease and ALS.
Read more...
Read Less...
Who Should Attend?
This webinar will appeal to:
- Medical Device Manufacturers
- Medium-to-Large Pharma and CROs
- Director/VP/Head of Precision Medicine
- Chief Medical Director
- Director/VP/Head of Digital Innovation/Engagement
- Scientists, Engineers and Data Scientists
What You Will Learn
Attendees will learn about:
- Industry environment and opportunities that engendered creation of innovation labs
- Why innovation labs are positioned to rapidly springboard novel technologies without disrupting existing organizational operations and processes
- How innovation labs prioritize and deliver innovation concepts best aligned with product roadmaps to facilitate technology integration
- How innovation labs support an environment of innovation and creative thinking within organizations
Xtalks Partner
Clinical ink
Clinical ink is a global life science company bringing data, technology, and patient-centric research together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, behavioral and dropout prediction, eConsent, telehealth, and digital biomarkers advancements (including use of Continuous Glucose Monitoring for detection of hypoglycemia), support the next generation of clinical trials and ultimately the clinical management of patients.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account